IndraLab

Statements

USP18 activates S phase. 2 / 2
| 2
reach
"Compared with the control cells, USP18 overexpression alone slightly promoted proportion of S phase cells (from 31.15% to 34.88%) and reduced proportion of G2/M phase cells (from 16.36% to 12.90%)."
35180471
reach
"Importantly, when cells were treated with paclitaxol, USP18 overexpression could effectively increase the proportion of S phase (from 21.14% to 29.09%) and eliminate G2/M phase arrest (from 23.39% to [MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"
35180471